BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37933684)

  • 1. CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
    Richter J; Oschlies I; Kock K; Wüseke T; Haag J; Koch K; Klapper W
    J Pathol; 2024 Feb; 262(2):189-197. PubMed ID: 37933684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4
    Oschlies I; Kock K; Wüseke T; Richter J; Koch K; Wehkamp U; Klapper W
    Histopathology; 2023 Feb; 82(3):485-494. PubMed ID: 36341542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal B-cell proliferations developing in the background of primary cutaneous CD4
    Ates Ozdemir D; Akdoğan N; Okay M; Uner A; Saglam A
    J Cutan Pathol; 2022 Nov; 49(11):971-977. PubMed ID: 35871674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder in a young woman.
    Leeolou MC; Young PA; Saleem A; Narala S; Bae GH
    Dermatol Online J; 2022 Dec; 28(6):. PubMed ID: 36809093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
    Cetinözman F; Jansen PM; Willemze R
    Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar.
    Aria AB; Wilmas K; Kim EJ; Aung PP; Duvic M
    Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation.
    Kim EJ; Aria AB; Wilmas K; Lewis DJ; Torres-Cabala CA; Nunez C; Dabaja BS; Duvic M
    Pediatr Dermatol; 2019 Jan; 36(1):e23-e26. PubMed ID: 30548331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Cutaneous CD4
    Maurelli M; Colato C; Gisondi P; Girolomoni G
    J Cutan Med Surg; 2017; 21(6):502-506. PubMed ID: 28605998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria.
    Bakr F; Wain EM; Wong S; Palmer R; Robson A
    Am J Dermatopathol; 2021 Dec; 43(12):e190-e196. PubMed ID: 33989212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous CD4
    Plumptre IR; Said JT; Sheu Song J; Corey K; LeBoeuf NR
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29862. PubMed ID: 35730956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review.
    Plumptre IR; Said JT; Sun T; Larocca C; Virgen CA; Kupper TS; Fisher DC; Devlin PM; Elco CP; Song JS; LeBoeuf NR
    Leuk Lymphoma; 2022 Dec; 63(12):2832-2846. PubMed ID: 35862569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoproliferative disorder: Report of a case and review of the literature.
    Keeling BH; Gavino ACP; Admirand J; Soldano AC
    J Cutan Pathol; 2017 Nov; 44(11):944-947. PubMed ID: 28749588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category.
    Williams VL; Torres-Cabala CA; Duvic M
    Am J Clin Dermatol; 2011 Dec; 12(6):389-401. PubMed ID: 21863906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma.
    Alberti-Violetti S; Torres-Cabala CA; Talpur R; Corti L; Fanoni D; Venegoni L; Berti E; Duvic M
    J Cutan Pathol; 2016 Dec; 43(12):1121-1130. PubMed ID: 27550169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group.
    Beltzung F; Ortonne N; Pelletier L; Beylot-Barry M; Ingen-Housz-Oro S; Franck F; Pereira B; Godfraind C; Delfau MH; D'Incan M; Vergier B
    Am J Surg Pathol; 2020 Jul; 44(7):862-872. PubMed ID: 32271188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
    Magro CM; Olson LC; Fulmer CG
    Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous lymphoproliferative disorders: Back to the future.
    Willemze R
    J Cutan Pathol; 2024 Mar; ():. PubMed ID: 38499969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas.
    Leclaire Alirkilicarslan A; Dupuy A; Pujals A; Parrens M; Vergier B; Robson A; Delfau-Larue MH; Ingen-Housz-Oro S; Chosidow O; Haioun C; Beylot-Barry M; Merlio JP; Copie-Bergman C; Gaulard P; Ortonne N
    Am J Surg Pathol; 2017 Dec; 41(12):1581-1592. PubMed ID: 28945625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors.
    Sarac E; Demirkesen C
    An Bras Dermatol; 2023; 98(5):720-722. PubMed ID: 37225627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.